Most health-conscious consumers have already ditched plastic containers, switched to filtered water, and overhauled their skincare routines. Clothing, however, remains a stubborn blind spot, and a new app called Wove wants to change that. Launched th…
HistoSonics has received regulatory approval from Taiwan’s Food and Drug Administration for its Edison Histotripsy System, a non-invasive cancer treatment device that uses focused ultrasound to destroy tumours without cutting, radiation, or thermal dam…
The app is similar to a meeting notetaker: you can record doctor visits, and it will return an AI summary of the meeting, with the next steps, all of which you share with family and friends if you want to.
In a healthcare environment shaped by protocols and time constraints, many people often experience long journeys marked by inconclusive answers and persistent symptoms. Dr. Jeffrey L. Brown, founder of Hormone Health with Dr. Brown, positions his work …
Two-thirds of American women between 38 and 50 say they felt better prepared to go through puberty than perimenopause. The statistic, from a nationally representative survey commissioned by Flo Health and conducted by Wakefield Research, captures som…
The Copenhagen company says its Symphony model has outscored OpenAI on HealthBench Professional, and is offering credits and regulatory help to founders building healthcare AI worldwide. Corti, the Copenhagen-based clinical AI company, has launched a n…
Bristol Myers Squibb has signed a deal worth up to 15.2 billion dollars with Jiangsu Hengrui Medicine, China’s largest pharmaceutical company by market capitalisation. The agreement covers 13 early-stage drug programmes across oncology, haematology, …
Ditto, an Amsterdam-based health-tech building AI-generated summaries of medical appointments for patients, has raised €7.6m, the company said on Monday. The round is led by Heal Capital with participation from Rubio Impact Ventures. Earlier backer Chr…
Novo will take an equity stake in Cellular Intelligence and is in line for future milestone payments and royalties. The startup plans to apply its AI platform to STEM-PD, a stem-cell-derived treatment Novo discontinued last October. Novo Nordisk has ha…
A state investigator in Pennsylvania created an account on Character.AI, opened a conversation with a chatbot called Emilie, and told it he was feeling depressed. Emilie responded that she was a psychiatrist, that she had attended Imperial College Lond…